Editorial Board — Medscape Psychiatry & Mental Health

Board Members

  • Scott H. Kollins, PhD
    • Duke University Medical Center
      Durham, North Carolina
  • Jeffrey A. Lieberman, MD
    • Columbia University College of Physicians and Surgeons
      New York Presbyterian Hospital
      New York, NY
  • Jon McClellan, MD
    • University of Washington
      Seattle, Washington
      Child Study and Treatment Center
      Lakewood, Washington
  • Drew Ramsey, MD
    • Columbia University
      New York, New York
  • Stephen M. Strakowski, MD
    • Professor of Psychiatry and Behavioral Neuroscience
      Psychology, and Biomedical Engineering,
      University of Cincinnati College of Medicine
  • Michael E. Thase, MD
    • Pennsylvania School of Medicine
      Philadelphia, Pennsylvania
 

Board Member Details

Christoph U. Correll, MD
Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York; Investigator, Center for Psychiatric Neurosciece, Feinstein Institute for Medical Research, Manhasset, New York; Medical Director, Recognition and Prevention Program, Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, New York

Christoph U. Correll, MD, has disclosed the following relevant financial relationships:
Serve(d) as consultant and/or advisor to or has received honoraria from: Alkermes, Inc; Forum; Gerson Lehrman Group; IntraCellular Therapies; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Lundbeck, Inc; Medavante; Medscape; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc; ProPhase; Sunovion; Supernus; Takeda Pharmaceuticals North America, Inc.; Teva Neuroscience, Inc.
Provided expert testimony for: Bristol-Myers Squibb Company; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.
Served on Data Safety Monitoring Board for: Lundbeck, Inc; Pfizer Inc Received grant support from: Takeda Pharmaceuticals North America, Inc

Emily Deans, MD
Emily Deans, MD

Instructor of Psychiatry, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts; Psychiatrist, Wellcare Physicians Group, Norwood, Massachusetts

Emily Deans, MD, has disclosed the following relevant financial relationships:
Received income in an amount equal to or greater than $250 from: Psychology Today

Robert L. Findling, MD
Robert L. Findling, MD

Professor, Department of Psychiatry, John Hopkins University; Director, Child & Adolescent Psychiatry, Johns Hopkins Hospital, Baltimore, Maryland

Robert L. Findling, MD, has disclosed the following relevant financial relationships:
Has received research support, acted as a consultant, or served on a speakers bureau for:
Alexza Pharmaceuticals; American Academy of Child & Adolescent Psychiatry; American Physician Institute; American Psychiatric Press; AstraZeneca; Bracket; Bristol-Myers Squibb; Clinsys; Cognition Group; Coronado Biosciences; Dana Foundation; Forest; GlaxoSmithKline; Guilford Press; John Hopkins University Press; Johnson & Johnson; KemPharm; Lilly; Lundbeck; Merck; National Institutes of Health; Novartis; Noven; Otsuka; Oxford University Press; Pfizer; Physicians Postgraduate Press; Rhodes Pharmaceuticals; Roche; Sage; Seaside Pharmaceuticals; Shire; Stanley Medical Research Institute; Sunovion; Supernus Pharmaceuticals; Transcept Pharmaceuticals; Validus; WebMD

Bradley Gaynes, MD, MPH
Bradley Gaynes, MD, MPH

Professor, Department of Psychiatry, Associate Chair of Research Training and Education, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Bradley Gaynes, MD, MPH, has disclosed no relevant financial relationships.

Joseph F. Goldberg, MD
Joseph F. Goldberg, MD

Clinical Professor of Psychiatry, Icahn School of Medicine, New York, New York

Joseph F. Goldberg, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Sunovion
Serve(d) as a speaker or member of a speakers bureau for: Vanda Pharmaceuticals; Takeda Pharmaceuticals North America, Inc.; Lundbeck, Inc.; Merck & Co, Inc; Sunovion; Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Received income in an amount equal to or greater than $250 from: Medscape

Eric Hollander, MD
Eric Hollander, MD

Professor of Psychiatry, Albert Einstein College of Medicine; Director, Autism and Obsessive-Compulsive Spectrum, Anxiety, and Depression Program, Einstein-Montefiore Medical Center, Bronx, New York

Eric Hollander, MD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or member of a speakers bureau for: Shire; Sunovion Received research grant from: Roche; Caremark; Takeda Pharmaceuticals, Inc; Enzymatica

Scott H. Kollins, PhD
Scott H. Kollins, PhD

Professor and Vice-Chair for Research Strategy & Development, Department of Psychiatry and Behavioral Science, Duke University Medical Center, Durham, North Carolinaa

Scott H. Kollins, PhD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Akili Interactive; Alcobra Pharma; Atentiv; Ironshore; Neurovance; Purdue Pharma L.P.; Rhodes Pharmaceuticals; Shire; SK Life Science; Sunovion; Tris; Behavioral Innovations Group
Received research grant from: Akili Interactive; Alcobra Pharma; Atentiv; Ironshore; Arbor; Neos; Neurovance; Purdue Pharma L.P.; Rhodes Pharmaceuticals; Shire; Sunovion; Tris Have a 5% or greater equity interest in: Behavioral Innovations Group
Received income in an amount equal to or greater than $250 from: Akili Interactive; Alcobra Pharma; Atentiv; Ironshore; Neurovance; Purdue Pharma L.P.; Rhodes Pharmaceuticals; Shire; SK Life Science; Sunovion; Tris

Jeffrey A. Lieberman, MD
Jeffrey A. Lieberman, MD

Chairman, Department of Psychiatry, Columbia University; Director, Department of Psychiatry, New York State Psychiatric Institute, New York, New York

Jeffrey A. Lieberman, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Clintara; Intracellular Therapies
Received research grant from: Alkermes; Biomarin; EnVivo/Forum; Genentech; Novartis/Novation; Sunovion
Patent: Repligen

Jon McClellan, MD
Jon McClellan, MD

Professor, Department of Psychiatry, University of Washington, Seattle; Medical Director, Child Study and Treatment Center, Lakewood, Washington

Jon McClellan, MD, has disclosed the following relevant financial relationships:
Received research grant from: National Institute of Mental Health; National Alliance for Research in Schizophrenia and Affective Disorders

Drew Ramsey, MD
Drew Ramsey, MD

Assistant Clinical Professor, Department of Psychiatry, Columbia University, New York, New York

Drew Ramsey, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: InterContinental Hotels Group; National Kale Day 501(c)3
Received income in an amount equal to or greater than $250 from: Sharecare

Stephen M. Strakowski, MD
Michael E. Thase, MD

Professor of Psychiatry and Behavioral Neuroscience, Psychology, and Biomedical Engineering, University of Cincinnati College of Medicine; Senior Vice President, Strategy and Transformation, University of Cincinnati Health, Cincinnati, Ohio

Stephen M. Strakowski, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Procter & Gamble; Sunovion

Michael E. Thase, MD
Michael E. Thase, MD

Professor, University of Pennsylvania School of Medicine, Mood and Anxiety Disorders Treatment & Research Program, Philadelphia, Pennsylvania

Michael E. Thase, MD, has disclosed no relevant financial relationships.